We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01394211
Recruitment Status : Terminated (Slow accrual)
First Posted : July 14, 2011
Last Update Posted : March 31, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Arizona

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 12, 2012
  Study Completion Date : April 12, 2012